Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer. Wang C, Aikemu B, Shao Y, Zhang S, et al. BMC Cancer 2022;22:818.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang C, Aikemu B, Shao Y, Zhang S, et al. Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer. BMC Cancer 2022;22:818.
PMID: 35883111